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Abstract
In this work, molecular dynamics (MD) simulation of the interaction of three mutants, G3V, G5V and G10V, of the human
immunodeficiency virus (HIV) gp41 16-residue fusion peptide (FP) with an explicit palmitoyloleoylphosphatidyl-ethanolamine (POPE) lipid
bilayer was performed. The goals of this work are to study the correlation of the fusogenic activity of the FPs with the mode of their
interaction with the bilayer and to examine the roles of the many glycine residues in the FP in the fusion process. The results of this work
corroborate the main conclusion of our earlier MD work of the WT FP and several mutants with polar substitution. These two studies provide
correlation between the mode of insertion and the fusogenic activity of these peptides and support the hypothesis that an oblique insertion of
the fusion domain of the viral protein is required for fusogenic activity. Inactive mutants interact with the bilayer by a surface-binding mode.
The results of this work, combined with the results of our earlier work, show that, while the secondary structures of the wild-type FP and its
mutants do not affect the fusogenic activities, the conformational flexibility appears to be an important factor. The active WT FP and its
partially active mutants, G3V and G5V, all have significant conformational transitions at one of the glycine sites. They occur at Gly5 in FP-
wt, at Gly10 in FP-G5V and at Gly13 in FP-G3V. Thus, a glycine site in each of these active (or partially active) FPs provides conformational
flexibility. On the other hand, the inactive mutants FP-G10V, FP-L9R and FP-V2E do not have any conformational transitions except at
either terminus and thus possess no conformational flexibility. Thus, the results of this work support the suggestion that the role of glycine
residues in the fusion domain is to provide the necessary conformational flexibility for fusion activity.
The glycines also form a ‘‘glycine strip’’ in the FP that locates on one (the less hydrophobic) face of the helix (the ‘‘sided helix’’).
However, whether this ‘‘glycine strip’’ is disrupted or not does not seem to correlate with the retention of fusogenic activities. Finally,
although the FLGFL (8–12) motif is absolutely conserved in the HIV fusion domain, a well-structured motif stabilized by hydrogen bonding
does not appear to be required for activity. In fact, hydrogen bonding in this motif was found to be missing in FP-G3V and FP-G5V. Both of
these mutants are partially active.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Enveloped viruses such as human immunodeficiency
virus (HIV) and influenza virus infect their target cells by
cell-specific binding to the cell membrane followed by the
fusion of the viral enveloped membrane with cellular
membranes [1]. Usually, only one viral protein is respon-
sible for the actual membrane fusion step. For many viruses,
a segment of the fusion protein usually located at the N-
terminus of the fusion protein is responsible for the initial
stage in the membrane fusion process [2]. This segment is
generally referred to as the fusion domain or fusion peptide
(FP). The interaction of the FP with membranes has many
membrane perturbing properties [3] and accelerates the rate
of liposome fusion in model membrane systems. The HIV-1
fusion protein, glycoprotein gp160, contains two noncova-
lently associated subunits, gp120 and gp41 [1]. The subunit
gp120 contains sites for viral binding to target cells con-
taining CD4 [4] and chemokine receptors [5–7], while the
transmembrane subunit, gp41, is responsible for the mem-
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brane fusion process [8]. The N-terminal 16 residues of the
gp41 fusion domain (AVGIGALFLGFLGAAG) are mostly
hydrophobic, while the extended domain containing 23 or
33 residues contains more polar residues. The FP is highly
homologous with corresponding domains of other enveloped
viruses [9]. An absolutely conserved five-residue FLGFL
sequence at positions 8–12 is a prominent motif among the
HIV family, and was proposed to be essential in fusogenic
activities [10].
Mutagenesis studies of intact enveloped proteins as well
as the synthetic FPs strongly implicated the role of the FP
domain in mediating membrane fusion [11–13]. Mutations
with a polar residue in this domain either in intact gp41
fusion protein or in synthetic peptides, such as V2E and
L9R, reduce the fusogenic activities drastically [12–14].
The fusion domains of HIV-1 and many other enveloped
viruses such as HIV-2, SIV and influenza contain an
unusually large number of glycine residues. When the FP
is in an a-helical structure, it was proposed that the glycines
are located on one face of the helix (the glycine strip) facing
the aqueous phase [15], a situation similar to the trans-
membrane domains of class II MHC molecules [16]. Muta-
tion study involving systematically substituting the glycine
residues with the more hydrophobic and bulky valine
showed that these mutations either reduce or eliminate the
activity of the FP [13]. When the glycines at position 10 and
13 in the absolutely conserved FLGFLG motif are mutated,
the activity was found to be completely eliminated. Muta-
tions of the glycines at position 3 and 5 reduce but do not
eliminate the activity of the FP. The conservation of these
glycine residues and the aforementioned mutational study
[13] strongly suggests their special role in the fusion
process. However, despite speculations, the exact roles of
these glycine residues have not been determined.
Polarized attenuated total reflection infrared spectro-
scopy (ATR-IR) has been used to determine the orientation
of FPs with respect to the membrane surface [17,18]. It was
suggested that, based on the correlation of the tilt angle of
the inserted FP with respect to the membrane interface and
the fusogenic activity of the FP, the oblique insertion of the
viral FP is required for fusogenic activities. Inactive FP
mutants orient parallel or more parallel to the membrane
surface instead. Results from NMR [19] and ESR power
saturation techniques [20,21] for the influenza HA2 FP also
reached such a conclusion.
To date, only a few modeling/simulation studies on the
interaction of viral FPs with membrane have been carried
out. Hydrophobic moments and hydrophobic index have
been used to estimate the interaction of the HIV and other
FP’s with membrane. Efremov et al. [22] used Monte Carlo
simulation to study the orientation of the influenza hemag-
glutinin HA2 (1–20) FP in a lipid bilayer represented by a
two-phase slab model. Bechor and Ben-Tal [23] used molec-
ular dynamics (MD) in an implicit solvent model to study the
orientation of the same FP with respect to the membrane and
found that the lowest free energy configuration of the system
is the parallel (between the peptide helical axis and the
membrane-water interface) orientation rather than the obli-
que orientation suggested from experimental results [19,24].
The authors attributed the discrepancy to the lack of head
group–peptide interaction and the lack of peptide-induced
membrane deformation in the implicit solvent model. Re-
cently, we reported the first MD simulation study of the
HIV-1 FP in an explicit palmitoyloleoylphosphatidyl-etha-
nolamine (POPE) lipid bilayer, in which the wild-type FP, its
V2E and L9R mutants and a shortened peptide consisting of
the 5–16 segment were studied. The results showed that the
active WT peptide is inserted into the bilayer at f 45j,
while the inactive mutants and fragment bind to the surface
of the bilayer and lie parallel to the bilayer surface [25].
Thus, it demonstrated that MD in explicit membrane model
can produce results that are consistent with experiments. The
MD results are in agreement with the hypothesis that in
order for the FP to be active, it must be inserted into the
bilayer in an oblique angle.
In this work, three mutants of the 16-residue FP of the
HIV-1 gp41 protein involving substituting glycine residues
in three different locations with a more hydrophobic and
bulky residue valine, G3V, G5V and G10V (hereafter
referred to collectively as the G-mutants), were studied by
MD simulation in an explicit POPE bilayer. POPE bilayer
was used because previous work [17] showed that the WT
FP can only cause fusion in large unilamllar vesicles when
PE is present and that the orientation of the FP with respect
to the bilayer surface depends on the presence of PE. The
purpose of this work is to test the hypothesis that in order
for the FP to be active, it must be inserted into the bilayer in
an oblique angle, and to determine the roles the many
glycine residues in the FP play in the membrane interaction
and fusion process.
2. Methods
The explicit peptide–POPE bilayer in water was sub-
jected to MD simulations and minimizations using NAMD
[26] version 2.4 running on a dual processor Linux system.
The all-atom CHARMM PARAM-27 force field was used
for the peptides [27] and lipids [28]. The nonbonded list was
generated using a group-based cutoff of 14.0 A˚. The van der
Waals (vdW) interactions were smoothly switched from
10.0 to 12.0 A˚. The long-range electrostatic interactions
were handled by the particle mesh Ewald (PME) algorithm
[29] using a 48 48 81 grid and a h-spline interpolation
of 4th order. All the peptides were constructed in an a-
helical conformation. The N-terminus was protonated and
the C-terminus was modeled as a carboxamide. The coor-
dinates for the POPE system were obtained from Professor
Helmut Heller’s laboratory (http://www.lrz-muenchen.de/
~heller/membrane/membrane.html) and a bilayer slice of
50 50 A˚ from the center of the bilayer system was used
for simulation. The procedure for making the initial POPE
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bilayer is as reported in our previous work [25]. The peptide
was next inserted into the upper leaflet of the bilayer
keeping the helical axis perpendicular to the bilayer surface.
The POPE and water molecules overlapping with the pep-
tide were deleted. The final bilayer had 33 and 40 lipid
molecules on the upper and lower leaflets of the bilayer,
respectively. The SHAKE algorithm [30] was used to fix the
lengths of bonds involving hydrogen atoms. The Newton’s
equations of motion were integrated every 2 fs using the
MTS Impulse-Verlet (r-RESPA) algorithm. Full electro-
statics integration was done every step. Periodic boundary
conditions were applied to the system to prevent distortions
at the boundary of the system as a result of exposure to
vacuum. The system was minimized for 2000 cycles using
steepest descents to remove bad vdW contacts. The system
was then heated in steps of 25 K every 0.2 ps until it reached
the simulation temperature of 320 K. Following heating, the
temperature was reassigned to 320 K every 0.2 ps for
another 20 ps. The temperature of the system was then
maintained at 320 K during the entire data sampling period.
The nonbonded list was updated every 10 steps. A NPT
ensemble was used during data sampling. The collision
frequency of the Langevin piston was set to 25 ps 1 and
the mass of the piston to 500 amu [31]. The pressure was
maintained by changing the box length in the Z-direction
along the bilayer axis. The surface area was kept constant.
During this stage, the trajectory was sampled every 0.5 ps.
The total simulation time was 2.0 ns for each FP.
3. Results
3.1. The insertion of the fusion domain
Since the peptides maintained their helical nature over a
major part of the sequence during the entire simulation (see
discussion later), the orientation of the peptides was meas-
ured by the tilt angle of the helical axis of the peptides with
respect to the bilayer normal. The time evolution of the tilt
angle of the helical axis for the three mutants, G3V, G5V
and G10V, are compared with that of the wild-type peptide
previously studied in the same POPE bilayer [25]. In the
initial configuration of all these peptides, the helical axis
was oriented parallel to the bilayer normal (i.e. perpendic-
ular to the bilayer surface). The helical axis slowly tilted
during the simulation in each case. For FP-wt, the helical
axis reached an equilibrium orientation of 44F 6j with
respect to the bilayer normal from f 300 ps on Ref. [25].
Significant changes in the helical axis orientation from that
of FT-wt were seen following the mutations. The mutants
FP-G3V and FP-G10V, oriented at 92F 17j and 82F 16j
with respect to the bilayer normal, respectively, after reach-
ing their equilibrium configurations. The structure of FP-
G5V, on the other hand, consists of two helical segments,
the 4–9 and 11–16 segments, orienting differently with
respect to the bilayer normal, with Gly10 acting as a hinge.
The tilt angles for these two segments were found to be
110F 18j and 82F 16j, respectively. Thus, the 11–16
segment lies essentially parallel to the interface, while the
4–9 segment evolved into an orientation in which the N-
terminus protrudes towards the membrane/aqueous inter-
face. Larger fluctuations were observed in these mutants
which emerged onto the surface of the bilayer than for the
wild-type FP that was inserted [25]. In particular, the 4–9
segment of FP-G5V experiences large fluctuations that
change the orientation of this segment from protruding
towards the aqueous phase to pointing towards the bilayer
interior (Fig. 1). The implication of the results in this work
is in good agreement with our earlier work on the HIV FP,
its mutants with polar substitutions and a shortened peptide
[25] in that the results support the hypothesis that active FP
inserts into the membrane at an oblique angle while inactive
and partially active mutants either bind onto the surface of
the membrane or insert only shallowly. The orientational
data do not provide differentiation between the completely
inactive G10V and the partially active G3V and G5V
mutants [13]. Overall, the conclusion from this work is in
support of the hypothesis linking oblique insertion to
fusogenic activities.
The gross position of the FPs in the lipid bilayer and its
location relative to the various components of the phospho-
lipids and water are illustrated in Fig. 2 for FP-G10V. The
positions of the side chains and backbones of the various
residues in the peptides in the POPE bilayer provide
information on the extent of the insertion of the various
peptides into and the interaction of the various groups of the
peptide with the bilayer. In Fig. 3, the locations of the
backbone and the side chains (average positions of the
heavy atoms on the backbone and the side chain, respec-
tively) of the peptides in the POPE matrix are shown. The
interfacial area of the bilayer between the lipids and water is
defined by the positions where the hydrocarbon and water
densities pass through 10% of their respective bulk values
[32]. The interfacial area in each system in Fig. 3 is
indicated by the two horizontal lines. The phosphate and
ethanolamine groups are distributed in the head group area
that is 2–3 A˚ closer to the aqueous phase than the interfacial
area (Fig. 2). FP-wt has its N-terminal segment inserted
deeper than the interfacial area while the C-terminal seg-
ment lies in the head group area. The G3V mutation causes
the peptide to lie entirely in the interfacial and head group
areas. There is a change of the orientations of 2–3 segment.
With the substitution of Val in position 3, the hydrophobic
Val2 is forced to rotate towards the aqueous phase, allowing
Val3 and Ile4 to face the hydrophobic interior of the bilayer.
In addition, the side-chains of Leu7 and Phe11 protrude into
the hydrophobic core. The ‘‘glycine strip’’ [13,14] observed
in FP-wt in our previous MD simulation [25], however, is
completely maintained, because even in FP-wt, Gly3 is on
the more hydrophobic face of the helix and is not part of
this glycine strip. Similarly, for FP-G10V, the side-chains
of Ile4, Leu7 and Phe11 are most responsible for the
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interaction of the hydrophobic core of the bilayer. For FP-
G5V, the N-terminal segment is more exposed to the
aqueous phase. The Val substitution at position 5 actually
causes Ile4 to insert less deeply into the bilayer than in FP-
wt. Thus, the side chains of Leu7, Phe8, Phe11 and Leu12
may account for most of the hydrophobic interactions of the
peptide with the bilayer. In both FP-G5V and FP-G10V,
with the Val residue (at positions 5 and 10, respectively) on
the less hydrophobic face of the helix, the glycine strip and
the ‘‘sided-helix’’ [15] properties, were partially disrupted
by the replacement of the glycine residue at positions 5 and
10, respectively.
3.2. The conformation and conformational transitions
FP-wt and the three mutants studied maintained their
helical structure over a major portion of the peptide through-
out the simulations. The helical region extends from 3 to 15 in
FP-G3V, and from 4 to 15 for FP-G10V. FP-G5V, however,
consists of two helical segments, the 4–9 and 11–16 seg-
ments, with Gly10 acting as a hinge between these two he-
lices. The angle between the two helical segments varied over
a wide range during the 2-ns simulation. Several previous
work has indicated that the conformation of the FPs is mostly
helical under the condition of low peptide loading (peptide/
Fig. 1. The time-evolution of the orientation of the helical axis with respect to the normal to the POPE bilayer for FP-G3V, FP-G10V and the two helical
components of FP-G5V. For comparison, the average orientation for FP-wt as determined by MD was 44F 6j [25].
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lipid ratio) [33,34]. A recent work using 13C-enhanced FTIR
[35] showed that the a-helical segment for the WT FP start
from Gly5 and extends to Ala15 in various membrane mim-
icking media. NMR work of the WT FP in sodium dodecyl-
sulfate micelles also revealed the same helical region [36].
For the most part, the /, w angles of each corresponding
residues of these peptides are similar and there are no major
differences between the secondary structures of the active
FP-wt, and the less active or inactive FP-G3V, FP-G5V
and FP-G10V (Table 1). This result supports the suggestion
that the variation in the secondary structure in the fusion
domain plays little or no role in their fusogenic activities
[34,37,18,25]. However, the conformational flexibility of
the FPs seems to have significant bearings on their fuso-
genic activities as will be discussed in the next section.
The hydrogen bonding patterns in these three mutants
have been analyzed from their MD trajectories. The criteria
for defining a hydrogen bond are an average acceptor (the
carbonyl oxygen in this case)-hydrogen distance of < 2.8 A˚
and an average O–H–N angle of >120j [38]. Hydrogen
bonding patterns characteristic of an a-helix, i.e., CMO (i)-
NH (i+ 4), and some CMO (i)-NH (i + 3), hydrogen bonds,
with the i, i+ 4 hydrogen bonds being usually the stronger
as judged by the shorter distance between the O and H
atoms and the larger O. . .H–N angle, are observed through
most part of all four of the peptides, indicating an a-helical
structure. The exceptions are in the region from Leu7 to
Phe11 for FP-G5V and from Leu9 to Phe11 for FP-G3V,
where the i, i+ 3 and i, i+ 4 hydrogen bonds with the amide
protons are missing (or are much weaker) (Table 2). This
break in hydrogen bonding is similar to the FP-wt case
where the i, i+ 3 and i, i + 4 hydrogen bonds are missing
from Ile4 to Leu7 [5]. The Gly to Val mutation clearly
increases the overall hydrophobicity of the mutants and may
increase the a-helical propensity. The latter effect can be
seen most clearly in G10V where the a-helical structure is
more prevalent than the WT and other G-mutants (Table 2).
Yet, it is the least active among this group of FPs. Thus, an
increase in a-helical propensity is not correlated with
increased fusogenic activities.
The loss of hydrogen bonding described above is accom-
panied by increased conformational flexibility in the affected
region. It appears from this work and from our earlier MD
work [25] that higher conformational flexibility, in the form
of conformational transitions as well as larger root mean
square (rms) variations in the /w angles of the relevant
residues (Table 1), is exhibited by the active FP-wt, and the
partially active G5V and G3V mutants. The conformational
transitions center at Gly5 in FP-wt, at Gly10 in FP-G5V and
at Gly13 in FP-G3V (Fig. 4). In addition to FP-G5V, where
the transitions take place at Gly10 as described earlier, in FP-
G3V, there are concerted transitions for /(13) and w(12) at
1.2 ns during the 2-ns simulation (Fig. 4). This conforma-
tional transition persisted for about 400 ps and the peptide
returned to the original conformation, causing the peptide to
go from a linear to a V-shaped form. Our previous work [25]
showed that the transitions for FP-wt occurred at the phi
angle of Ala6 (and at Gly3 and Leu9) and psi angle of Gly5
leading the peptide to go from a linear to a V-shaped form
pivoted at Gly5. Studies of the influenza HA FP also showed
similar hinge type of conformation [21]. In contrast, there is
little conformational flexibility in the inactive G10V mutant
Fig. 2. The distribution of the densities of the backbone of the peptide FP-G10V, the lipid hydrocarbon chains, choline and phosphate groups along with water
in the FP-G10V/POPE bilayer system.
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as shown in this study and in the inactive V2E mutant in our
earlier work [25]. In both cases, the hydrogen bond network
extends throughout the peptide (Table 2 and Ref. [25]).
Analysis of the interaction between the CMO oxygen and
the N–H proton of the peptide backbone with water via the
respective RDF provided corroborative information on the
intermolecular hydrogen bonding in these peptides. The
CMO from C-terminal residues 13–16 in each FP are all
well hydrated because they are not involved in the (i, i+ 3),
or (i, i + 4) intramolecular hydrogen bonding. For the rest of
the peptides, the RDFs showed that the carbonyl oxygen
atoms of Leu9, Gly10, Leu12 and, to a lesser extent, of Gly5
and Ala6, in FP-G3Vare hydrated by water. Similarly, in FP-
G5V, the carbonyls of residues Leu7–Leu12 are strongly
hydrated. This partially accounts for (or is the result of) the
weakening or breaking of the hydrogen bonding in these
respective segments. In contrast, the carbonyls of only the C-
terminal segment 12–16 in FP-G10V were found to be
significantly hydrated as described above because of the
uninterrupted hydrogen bonding pattern in the 4–15 seg-
ment in this peptide.
The strongest hydrogen bonds were found in the FLGFL
(8–12) motif and extending towards the C-terminus for FP-
wt and for the V2E and L9R mutants [25]. This is also the
case for the inactive FP-G10V from the present study (Table
2). However, hydrogen bonding in this motif was found to
be largely or completely missing in FP-G3V and in FP-
G5V, both of which possess partial fusogenic activity. Thus,
having a well-structured FLGFL motif stabilized by hydro-
gen bonding does not seem to be an essential structural
feature for fusogenic activities, despite the absolute con-
servation of this motif in various HIV-1 strains.
3.3. Peptide hydration and peptide–head group interac-
tions
In the previous section, the hydration of the CMO groups
in the mid-section of the peptide in relation to the existence
or the lack of intramolecular hydrogen bonds was discussed.
The CMO of the C-terminal segment of these peptides are
also more hydrated, indicating greater exposure to the
aqueous phase consistent with the insertion pattern and the
locations of the C-terminal segment with respect to the
membrane–water interface.
The N-terminal peptide bond of these mutants, as is in
FP-wt, is not significantly exposed to the hydrophobic
environment because Ala1 is either oriented upward towards
the interfacial area, as is the N-terminus in influenza HA2 FP
[19,20], or is located in the interfacial area. Instead, the NH3
+
group of Ala1 of these peptides is significantly hydrated and
it has strong interactions with the phosphate head groups of
POPE. This indicates that the N-terminus is close to the
interfacial area and the favorable interactions with the
negatively charged part of the head groups provide stabiliza-
tion of such a configuration. The role of the latter interaction
in stabilizing the configuration of the FP in the membrane
was also speculated in the study of Macosko et al. [20] in
their study of the influenza HA2 FP. This interaction and the
reluctance of the protonated N-terminus to be exposed to the
hydrophobic bilayer interior are the main reasons that the
peptides do not insert perpendicularly into the bilayer.
As in our previous study of FP-wt and its polar mutants
(L9R and V2E), very little interaction between the backbone
of the peptides with the phospholipid head groups was
Fig. 3. The distribution of the peptide backbone (.) and side chains (n) of
each residue in FP-G3V, FP-G5V and FP-G10V with respect to the
interfacial region of the POPE bilayer system (indicated by the two
horizontal lines in each figure). A similar plot for FP-WTwas given in Ref.
[25]. Note that these figures have not been drawn to reflect the angle of
orientation with respect to the bilayer accurately.
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found in these three mutants, nor was there any significant
interactions between the mostly hydrophobic side chains
and the lipid head groups. By examining the RDFs between
the CMO groups of the peptide backbone and ethanolamine
groups on the lipid and between the amide protons on the
peptides and the phosphate groups on the lipids, nonnegli-
gible interactions were found only between the N-terminal
CMO with the amine groups in the ethanolamine head
groups in FP-G3V, and the CMO groups of Ala15 and
Gly16 in FP-G10V. An exception was found in FP-G5V.
Since the middle (Leu7–Phe11) part of this peptide lacks
intramolecular hydrogen bonds, the CMO of Leu9 was also
found to interact rather strongly with the ethanolamine head
groups. Interactions between the amide protons on the
backbone of the peptide with the phosphate head groups
were not observed except for both terminal residues in FP-
G10V and for the N-terminal residues for the other two
mutants. Since the N-terminal segment of FP-G5V pro-
trudes towards the aqueous phase, the interaction of the Ala1
amino group of FP-G5V with the phosphate head groups
was weaker than the other two mutants, while the hydration
of the N-terminal amino group was stronger. Based on the
lack of interactions of either the backbone or the side chains
of the gp41 FPs with the lipid head groups and based on the
positions of the hydrophobic side chains (primarily of Ile4,
Leu7, Phe8, Phe11 and Leu12), it can be inferred that the
interaction of the FPs with the bilayer is primarily through
the hydrophobic side chains.
Table 1
/ and w values (in degrees) for the wild-type fusion peptide and its mutants in a POPE bilayer
Residue Phi and psi valuesa
FP-WT FP-G3V FP-G5V FP-G10V
/ w / w / w / w
2  85F 18 132F 14  94F 14 86F 14  98F 22 168F 13  110F 14 129F 17
3 102F 22  13F 24  68F 10  55F 15 70F 16  113F 23  63F 19  107F 19
4  72F 14  57F 10  65F 12  36F 13  73F 10  27F 11  69F 9  39F 9
5  62F22  18F36  65F 11  36F 15  72F 10  45F 9  64F 10  31F11
6  96F31  63F 13  69F 13  44F 13  60F 10  42F 10  70F 10  43F 9
7  90F 15  54F 12  72F 12  49F 13  61F10  38F 12  61F10  42F 9
8  75F 12  34F 12  66F 12  54F 10  75F 13  52F 11  63F 10  43F 10
9  47F 19  44F 16  70F 10  27F 13  78F 13  44F24  62F 10  39F 9
10  65F 11  35F 12  66F 12  38F 13  130F29 44F39  64F 9  40F 10
11  74F 11  39F 9  70F 11  51F11  88F24  51F12  64F 10  51F 9
12  65F 9  40F 10  66F 14  6F64  63F 13  48F 14  66F 10  32F 13
13  67F 11  30F 15  25F91  41F23  77F 15  31F 20  72F 13  31F17
14  72F 12  37F 12  80F 15  51F14  78F 15  48F 14  81F14  47F 15
15  73F 12  55F 17  77F 13  51F 38  74F 12  36F 45  78F 15  42F 80
The dihedral angles with large rms deviations due to conformational transitions (not including those at or close to the termini) are depicted in bold.
a Values are reported as averageF rms deviations.
Table 2
Hydrogen bonding patterns for the wild-type fusion peptide and its mutants
H-bond Bond angles and bond distancesa
pattern
FP-WT FP-G3V FP-G5V FP-G10V
Angle Distance Angle Distance Angle Distance Angle Distance
2! 5 126F 14 2.49F 0.4
2! 6 – – – – – – 141F14 2.69F 0.4
3! 6 127F 14 2.69F 0.3
3! 7 145F 16 2.86F 1.0 158F 12 2.34F 0.4 158F 12 2.18F 0.3 152F 13 2.43F 0.4
4! 8 – – 152F 17 2.21F 0.4 146F 16 2.50F 0.4 158F 11 2.25F 0.3
5! 8 122F 14 2.68F 0.4
5! 9 – – 139F 27 2.69F 0.8 163F 10 2.00F 0.2 157F 11 2.15F 0.3
6! 10 – – 129F 17 2.69F 0.5 144F 20 2.26F 0.4 162F 10 2.05F 0.2
7! 11 – – 146F 16 2.43F 0.5 – – 154F 12 2.66F 0.4
8! 11 126F 16 2.44F 0.3 123F 15 2.69F 0.4 – – – –
8! 12 159F 12 2.11F 0.3 161F11 2.11F 0.3 – – 161F10 2.12F 0.2
9! 13 154F 14 2.10F 0.3 – – – – 158F 11 1.95F 0.2
10! 14 141F18 2.48F 0.5 – – – – 143F 18 2.42F 0.4
11!14 – – – – – – 123F 14 2.76F 0.4
11!15 149F 16 2.31F 0.4 139F 25 2.54F 0.7 149F 23 2.34F 0.6 157F 14 2.06F 0.3
12! 16 154F 21 2.16F 0.5 – – 135F 32 2.76F 1.1 135F 26 2.43F 0.6
a Bond angle is the O. . .H–N angle in degrees and the bond distance is the O. . .H distance in A˚. Values are reported as averageF rms deviations.
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3.4. The perturbation of the bilayer
In our earlier work [25], it was shown that the insertion
of FP-wt perturbed the bilayer order by increasing the length
of the interfacial area by f 1.2 A˚, while the inactive
mutants did not. The increase of the interfacial area has
been shown to be due to the disorientation of the lipid that
extends the lipid density towards the head group region,
rather than due to increased water penetration. In this work,
it was shown that the interaction of these three G-mutants
with the bilayer produced negligible perturbation of the
bilayer. In all three systems, the length of the interfacial area
in the upper leaflet was found to be essentially the same as
that of the lower leaflet. In both leaflets, the interfacial area
thickness was 3.0F 0.2 A˚. The results here showed that
surface binding or shallow insertion of the FP does not
produce observable perturbation of the membrane.
4. Conclusions
In this work, the results of an explicit MD study of the
interaction of three mutants of the HIV gp41 16-residue
fusion domain with a POPE lipid bilayer were presented.
The results of this work corroborate the main conclusion of
our earlier MD work of the WT FP and several mutants with
polar substitutions. These two studies provide correlation
between the mode of insertion and the fusogenic activity of
these peptides and support the hypothesis that an oblique
insertion of the fusion domain of the viral protein is required
for fusogenic activity [18,39]. Inactive mutants interact with
the bilayer by a surface-binding mode. One objective of this
work is to examine the roles of the many glycine residues in
the fusion domain. This work, when combined with the
result of our earlier work, showed that while the (mostly
helical) secondary structures of the wild-type FP and its
mutants do not affect the fusogenic activities, the conforma-
tional flexibility does appear to be an important factor. The
active WT FP and its partially active mutants, G3V and
G5V, all have significant conformational transitions at a
glycine site. They occur at Gly5 in FP-wt (see Fig. 5 in Ref.
[25]), at Gly10 in FP-G5V and at Gly13 in FP-G3V (Fig. 4).
Thus, a glycine site in each of these active (or partially
active) FPs provides conformational flexibility. On the other
hand, the inactive mutants FP-G10V, FP-L9R and FP-V2E
do not have any conformational transitions except at either
terminus (for example at Ala15 for FP-G10V) and thus
possess no conformational flexibility. Thus, the results of
this work suggest that one of the important roles of glycine
residues in the fusion domain is to provide the necessary
conformational flexibility for fusion activity. Previous work
on the gp41 FP revealed the controversies on whether the
Fig. 4. The conformational transitions for FP-G3V at Leu12 and Gly13 and for FP-G5V at Gly5. The /, w angles vs. time plot for Gly5 of FP-G10V is also
presented for comparison. No such transition at Gly5 or at any other residues was observed for the inactive FP-G10V except at Ala15 near the C-terminus.
T.C. Wong / Biochimica et Biophysica Acta 1609 (2003) 45–5452
FP adopts an a-helical or h structure. Even experiments
under similar sample conditions have shown both the a and
h structures [18,40–43]. It is hypothesized by some groups
that conformational polymorphism and/or the ability to
convert readily between a-helical and h-conformations of
the inserted FP are essential [3,44]. The conformational
variability may contribute to the flexibility of the fusogenic
complex during the membrane fusion process [45–47],
and/or allowing access of the FP to the trans monolayer
of the target membrane during membrane fusion [44].
Perhaps the conformational flexibility observed here is
needed to facilitate the ah conversion in the FPs or
the conformational changes required for the subsequent
fusion process.
The glycine residues form a ‘‘glycine strip’’ that locates
on one (the less hydrophobic) face of the helix. However,
whether this ‘‘glycine strip’’ is disrupted in the G3V and
G5V mutants does not seem to correlate with a loss of
fusogenic activities. Finally, although the FLGFL (8–12)
motif is absolutely conserved in the HIV fusion domain, a
well-structured motif stabilized by hydrogen bonding does
not appear to be required for activity. In fact, hydrogen
bonding in this motif was found to be missing in FP-G3V
and FP-G5V, both of which are partially active.
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